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Interstitial Inorganic Phosphate as
a Tumor Microenvironment Marker
for Tumor Progression
Andrey A. Bobko1,2, Timothy D. Eubank1,3, Benoit Driesschaert1,2, Ilirian Dhimitruka4,
Jason Evans5, Rahman Mohammad5, Elena E. Tchekneva5, Mikhail M. Dikov5 &
Valery V. Khramtsov1,2
Noninvasive in vivo assessment of chemical tumor microenvironment (TME) parameters such as oxygen
(pO2), extracellular acidosis (pHe), and concentration of interstitial inorganic phosphate (Pi) may provide
unique insights into biological processes in solid tumors. In this work, we employ a recently developed
multifunctional trityl paramagnetic probe and electron paramagnetic resonance (EPR) technique for
in vivo concurrent assessment of these TME parameters in various mouse models of cancer. While the
data support the existence of hypoxic and acidic regions in TME, the most dramatic differences, about
2-fold higher concentrations in tumors vs. normal tissues, were observed for interstitial Pi - the only
parameter that also allowed for discrimination between non-metastatic and highly metastatic tumors.
Correlation analysis between [Pi], pO2, pHe and tumor volumes reveal an association of high [Pi] with
changes in tumor metabolism and supports different mechanisms of protons and Pi accumulation in
TME. Our data identifies interstitial inorganic phosphate as a new TME marker for tumor progression.
Pi association with tumor metabolism, buffer-mediated proton transport, and a requirement of high
phosphorus content for the rapid growth in the “growth rate hypothesis” may underline its potential
role in tumorigenesis and tumor progression.
In recent decades, cancer research has experienced a paradigm shift from focusing exclusively on a seemingly
obvious target, malignant cells, toward appreciation of key roles of the tumor microenvironment (TME) in cancer progression and therapy1. TME includes the physical components such as extracellular matrix, blood vessel
endothelium, stromal and inflammatory cells, other supporting structures of the particular organ, and physiological components such as oxygen, pH, nutrients, waste products, signaling molecules, growth and pro-tumorigenic
factors. Among important physiological parameters of the TME, tissue hypoxia2 and acidosis3,4 are well recognized hallmarks in solid tumors associated with changes in metabolic pathways; including a higher dependence
on glycolysis5. The glycolytic phenotype of cancer cells that utilize glycolysis and lactic fermentation despite the
presence of appropriate oxygen supply are features shared by nearly all tumors. Recently, metabolic alterations in
cancer and, in particular the role of aerobic glycolysis first described by Otto Warburg in the 1920’s, are receiving
increasing attention. The dominant perception that ATP generated through anaerobic glycolysis is needed for a
high level of oncogene-induced proliferation is not unequivocally supported by available data. Alternatively, it has
been proposed that the glycolytic pathway provides necessary equivalents of carbon and electrons from NADPH
formed via interconnecting the pentose phosphate pathway for the synthesis of biomass. One of the consequences
of a metabolic shift towards upregulated glycolysis and NADPH formation is a high concentration of glutathione,
a major intracellular redox buffer.
High reducing capacity, hypoxia and acidosis of extracellular TME expose both cancer and non-transformed
cells to elevated production of reactive oxygen species while providing cancer cells with a selective advantage6.
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Figure 1. Multifunctional assessment of chemical microenvironment using trityl probes. (a) Set-up for
in vivo L-band EPR measurements of the tissue microenvironment parameters in living mice. Photograph
shows the anesthetized mouse between the magnets of the EPR spectrometer with the insert on the right
showing placement and positioning of the loop resonator on top of the measured tissue. (b) The scheme of
pH-dependent equilibrium between two ionization states of monophosphonated trityl probe, pTAM. (c) EPR
spectrum of pTAM with the insert on the right showing the extended view of the high-field component. (d) The
EPR linewidth of the pTAM is a pO2 marker (accuracy, ≈ 1 mmHg; pO2 range, 1–100 mmHg). (e) The fraction
of protonated pTAM is a pH marker in the range from 6 to 8.0 (accuracy, ±0.05). (f) Dependence of proton
exchange rate (expressed in mG) of the pTAM with inorganic phosphate on Pi concentration extracted by
spectra simulation (accuracy, ±0.1 mM, range, 0.1–20 mM)9,10. Note interstitial extracellular localization of the
pTAM probe: it does not penetrate into the cells due to bulky hydrophilic structures and the pTAM signal from
the blood is not detected by EPR due to signal broadening by pTAM complexation with plasma albumin47.
Specifically, TME acidosis has been proposed to be selectively more toxic to normal parenchymal tissues compared with invading cancers7. Noninvasive in vivo assessment of TME parameters such as oxygen (pO2) and
extracellular acidosis (pHe) may provide unique insights into biological processes in tumors, tumor progression,
aggressiveness and efficacy of anticancer therapies. In particular, concurrent multiparameter measurements allow
for the analysis of correlation between the TME parameters8. In this work, we employ an electron paramagnetic
resonance (EPR) technique for in vivo concurrent assessment of pO2, extracellular pH (pHe) and concentration of
interstitial inorganic phosphate (Pi) in TME in animal models of cancer. This technique is based on application of
a recently developed soluble multifunctional paramagnetic probe providing unsurpassed opportunity for in vivo
multiparameter measurements9,10 (see Fig. 1). Our data identifies interstitial inorganic phosphate as a new marker
of tumor progression. The associate of [Pi] with tumor metabolism11,12, buffer-mediated proton transport13, and a
requirement of high phosphorus content for the rapid growth in the “growth rate hypothesis14” may underline its
potential role in tumorigenesis, tumor progression and metastasis.

Results

In vivo EPR profiling of tissue microenvironment in normal mammary glands. Concurrent mul-

tiparameter measurements in the tissue microenvironment of normal mammary gland performed in FVB/N wild
type mammary glands (n = 23) yield the mean values being equal to 58 ± 3 (SE) mmHg of pO2, pHe =  7.1 ±  0.03
(SE) and [Pi] =  0.84 ± 0.07 mM (SE) as shown in Fig. 2. Individual measurements show significant biological
variations of these parameters around the mean values. Simultaneous data acquisition of all three parameters
using the same probe allows for correlation analysis between these parameters as presented in Fig. 3. A positive
correlation is found between pO2 and pHe in agreement with a higher contribution of glycolysis in tissue energy
metabolism at lower pO2 resulting in interstitial lactic acidosis. In addition, a negative correlation between pO2
and [Pi] may also reflect changes in bioenergetic status of the tissue. A decrease of [NTP]/[Pi] ratio accompanied
with [Pi] increase has been previously used as an indirect measure of the tissue bioenergetic status assessed with
31
P NMR12. No significant correlation has been observed between interstitial pHe and [Pi] values. The observed
correlations between pO2 and both pHe and [Pi] have been further supported by establishing anoxic conditions
in interstitial fluids by intratissue (i.t.) injection of an oxygen-consuming enzymatic system of glucose/glucose
oxidase (Fig. 3, red symbols).

EPR profiling of TME in a mouse model of spontaneous breast cancer. We performed multiparameter measurements in the TME of MMTV-PyMT transgenic mice which spontaneously develop breast cancer
and emulate human tumor staging15. The mean values of pO2 =  50 ± 3 mmHg (SE) and pHe =  6.99 ±  0.03 (SE)
are slightly lower compared to corresponding values in normal mammary glands supporting an appearance of
hypoxic and acidic regions in the tumor (see Fig. 2). The most dramatic changes were observed for concentration
of interstitial Pi measured in TME, mean value [Pi] =  1.8 ± 0.2 mM (SE), compared to that in normal mammary gland, [Pi] =  0.84 ± 0.07 mM (SE). The individual measurements show significant variations around the
mean values which allows correlation analysis between these three parameters and tumor volume as presented in
Figs 4 and 5. No significant correlation has been observed between tumor volume and any of the measured TME
parameters (Fig. 4).
Scientific Reports | 7:41233 | DOI: 10.1038/srep41233
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Figure 2. (a) Representative tumor burden (total weight, black columns) of MMTV-PyMT(+) mice (n =  10)
and mammary glands (red columns) of their wild type PyMT(−) age-matched littermates (n = 10). The values
of pO2 (b), pHe (c) and [Pi] (d) measured in tissue environment of normal mammary gland (MG, n =  23) and
tumor TME (T, n = 18). Error bars are SD. *p =  0.065, **p =  0.006, ***p =  6 ×  10−6.

Figure 3. Correlation between interstitial pO2, pHe and [Pi] values measured in normal mammary glands
(n = 23) of FVB/N wild type mice. The red symbols (n = 6) correspond to the measurements performed after
enzymatic oxygen depletion after i.t. injection of glucose/glucose oxidase system. (a) A positive correlation
(r =  0.5, p = 0.014 for black symbols; r =  0.64, p =  1.8 ×  10−4 for total data set) was found between pO2 and pHe.
(b) A negative correlation was found between pO2 and [Pi] (r =  −0.51, p = 0.013 for black symbols;
r =  −0.7, p =  2.3 ×  10−5 for total data set). (c) No significant correlation was found between pHe and [Pi]
(r =  0.19, p = 0.4 for black symbols; r =  −0.1, p = 0.65 for total data set). Blue lines represent linear fit for the
total data sets.

In contrast to normal mammary glands, no significant correlation was found between pO2 and pHe in tumors
(Fig. 5a), which might be attributed to tumor reliance on glycolysis independent of oxygen concentration. In
turn, negative correlation between pO2 and [Pi] (Fig. 5b) may reflect changes in bioenergetic status of the tissue
related to changes in oxygen supply. No significant correlation has been observed between interstitial pHe and [Pi]
values (Fig. 5c). The observed correlation between pO2 and [Pi] has been further supported by establishing anoxic
conditions in interstitial space by intratissue (i.t.) injection of oxygen-consuming enzymatic system of glucose/
glucose oxidase (Fig. 5c, red symbols).

EPR profiling of TME in non-metastatic and metastatic tumor xenografts.

We compared
subcutaneous (s.c.) xenografts established in immune deficient mice by injecting human lung adenocarcinoma
cells that differ in their metastatic properties: while it is extremely rare for parental PC14 cells to develop metastases, PC14HM cells derived from distant metastases are highly metastatic to various organs including lung16.
While PC14 cells form well encapsulated s.c. tumors, PC14HM tumors demonstrate high invasiveness as seen by
the invasive boarder (Fig. 6b). PC14HM cells also develop a significantly higher number of lung tumor nodules
upon intravenous injection (Fig. 6c). Both tumor xenografts grow at similar rates (Fig. 6a) and do not differ in the
degree of vascularization (Fig. 6e) allowing for comparison of their TME parameters dependent on tumor volume.

Scientific Reports | 7:41233 | DOI: 10.1038/srep41233
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Figure 4. Correlation between tumor volume and interstitial pO2, pHe and [Pi] values measured in the
TME of breast cancer in MMTV-PyMT transgenic mice (n = 18). The red symbols (n = 5) correspond to the
measurements performed after enzymatic oxygen depletion after i.t. injection of the glucose/glucose oxidase
system. No significant correlation was found between tumor volume and (a) pO2 (r =  0.07, p =  0.76), (b) pHe
(r =  −0.23, p = 0.28) and (c) [Pi] (r =  0.004, p = 0.99). Blue lines represent a linear fit for the total data sets.

Figure 5. Correlation between interstitial pO2, pHe and [Pi] values measured in the TME of breast cancer
in MMTV-PyMT transgenic mice (n = 18). The red symbols (n = 5) correspond to the measurements
performed after enzymatic oxygen depletion after i.t. injection of glucose/glucose oxidase system. (a) No
significant correlation (r =  0.01, p = 0.97 for black symbols; r =  0.23, p = 0.3 for total data set) was found
between pO2 and pHe. (b) A negative correlation was found between pO2 and [Pi] (r =  −0.4, p = 0.079 for black
symbols; r =  −0.62, p = 0.001 for total data set). (c) No significant correlation was found between pHe and [Pi]
(r =  −0.01, p = 0.7 for black symbols; r =  −0.23, p = 0.3 for total data set). Blue lines represent linear fit for the
total data sets.

Figure 7 shows the dependence of individual measurements of TME pO2, pHe and [Pi] on tumor volume. In
contrast to spontaneous developing tumors, both PC14 and PC14HM xenografts showed a correlation between
each pO2 and [Pi] with tumor volume. This might be due to a modification of the normal tissue microenvironment during tumor progression after injection of malignant cells. The measured values of pO2 and pHe are not
significantly different between the PC14 and PC14HM xenografts. Extracellular inorganic phosphate concentration, [Pi], was the only discriminating parameter between non-metastatic and metastatic tumors, being higher in
the highly metastatic PC14HM xenografts (Fig. 7c).
Correlation between pO2, pHe and [Pi] are shown in Fig. 8. Similar to spontaneous developing tumors, the
only significant correlation was found between pO2 and [Pi] (Fig. 8b).

Discussion

Noninvasive in vivo assessment of chemical TME parameters such as oxygen, pO2, extracellular acidosis, pHe, and
concentration of interstitial inorganic phosphate, Pi, may provide unique insight into biological processes in solid
tumors. However, until now there were no available techniques for the concurrent assessment of these physiologically important chemical TME parameters in living subjects. Recently, we designed a trityl paramagnetic probe9,10
with unique spectral properties that allows for simultaneous monitoring of tissue pO2, pHe and [Pi]. In this work,
this probe was successfully used in vivo in animal models of cancer using low-field L-band EPR spectroscopy that
allowed for a few cm tissue depth penetration of microwave field.
Comparison of the mean values of pO2 and pHe in TME of MMTV-PyMT transgenic mice which develop
spontaneous breast cancer with the corresponding parameters in normal mammary glands of their PyMT(-)
normal age-matched littermates shows slightly lower values in tumors supporting the existence of hypoxic and
Scientific Reports | 7:41233 | DOI: 10.1038/srep41233
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Figure 6. Lung metastatic properties and invasiveness of PC14 and PC14HM cells, and the growth of the
corresponding sub-cutaneous tumor xenografts. (a) Tumor growth volume measured upon progression of
non-metastatic PC14 and metastatic PC14HM tumor xenografts show no significant difference; 5 ×  106 PC14
or PC14HM cells were injected into flanks of NSG mice. (b) Photographs of the primary subcutaneous tumor
tissue slides stained with H&E; appearance of PC14HM tumor demonstrates its more invasive edge (brackets)
compared to the encapsulated edge of PC14 tumor (arrow). (c,d) NSG mice received retro-orbital injection
of 106 PC14 or PC14HM cells and lung metastases were enumerated 18 days later: (c) PC14HM cells have
remarkably higher ability to form lung tumors compared to PC14 cells; n = 5. Error bars are SD. *p <  0.005;
(d) Lung tissue sections stained with H&E. (e,f) CD34 immunostaining (brown) of PC14 and PC14HM tumors
demonstrate no difference in vessel density: (e) Average number of blood vessels per field, n = 5. Error bars are
SD; (f) Representative images of tumor sections. Arrows indicate some of CD34+ blood vessels. NM and HM are
abbreviations for PC14 and PC14HM cells.

acidic regions in TME in agreement with numerous literature data10,17–19. However, the most dramatic difference, about 2-fold higher concentration in tumors compared to normal mammary glands, was observed for
interstitial Pi. When we used the same approach in tumor xenograft models, the only parameter which allowed
for discrimination between non-metastatic PC14 and highly metastatic PC14HM tumors was interstitial Pi, the
concentration of which was significantly higher in the metastatic tumors. The observed elevated Pi concentration
in TME of breast tumors vs. normal mammary glands, and in highly metastatic tumor xenografts compared to
non-metastatic tumors raises questions about the role of interstitial inorganic phosphate in tumor progression
and metastasis. Among the other factors, alterations in interstitial fluid pressure and/or tumor blood flow could
influence the amount of inorganic phosphate observed in the extracellular compartment20. We did not observe a
difference in the degree of vascularization of the non-metastatic PC14 and metastatic PC14HM tumor xenografts
which suggests that this factor may not contribute to the difference in [Pi] between two types of xenograft tumors
(Fig. 6e,f).
Historically, endogenous phosphorus-containing metabolites related to energy metabolism (e.g. nucleoside
triphosphates, NTPs, phosphocreatine and Pi) were prime candidates to be used as 31P magnetic resonance
Scientific Reports | 7:41233 | DOI: 10.1038/srep41233
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Figure 7. Correlation between tumor volume (TV) and interstitial pO2, pHe and [Pi] values measured
in the TME of non-metastatic PC14 (n = 12) and metastatic PC14HM (n = 12) tumor xenografts. (a)
Significant correlation was found between pO2 and tumor volume for PC14HM xenografts (r =  −0.59,
p = 0.045 for PC14HM xenografts; r =  −0.44, p = 0.15 for PC14 xenografts and r =  −0.5, p = 0.014 for total
set of data). (b) No significant correlation was found between pHe and tumor volume (r =  0.02, p =  0.96 for
PC14HM xenografts; r =  −0.04, p = 0.9 for PC14 xenografts and r =  −0.015; p = 0.94 for total set of data). (c)
Significant correlation was found between [Pi] and tumor volume (r =  0.66, p = 0.02 for PC14HM xenografts;
r =  0.9, p =  3 ×  10−5 for PC14 xenografts and r =  0.73, p =  5 ×  10−5 for total set of data). Note significantly
higher [Pi] values for PC14HM xenografts compared to PC14 xenografts (mean [Pi] =  2.2 ± 0.2 mM and
[Pi] =  1.6 ± 0.2 mM, correspondingly; p = 0.047). Black and red lines represent linear fits for PC14 and
PC14HM data sets, respectively.

Figure 8. Correlation between interstitial pO2, pHe and [Pi] values measured in the TME of non-metastatic
PC14 (n = 12) and metastatic PC14HM (n = 12) tumor xenografts. (a) No significant correlation was found
between pO2 and pHe (r =  −0.19, p = 0.56 for PC14HM xenografts; r =  −0.03, p = 0.93 for PC14 xenografts and
r =  −0.16, p = 0.44 for total set of data). (b) A negative correlation was found between pO2 and [Pi] (r =  −0.7,
p = 0.01 for PC14HM xenografts; r =  −0.6, p = 0.04 for PC14 xenografts and r =  −0.5, p = 0.017 for total set of
data). (c) No significant correlation was found between pHe and [Pi] (r =  0.37, p = 0.23 for PC14HM xenografts;
r =  0.02, p = 0.95 for PC14 xenografts and r =  0.1, p = 0.6 for total set of data). Black and red lines represent
linear fits for PC 14 and PC14HM data sets, respectively.

spectroscopy (MRS)-measured markers to help differentiate tumors from normal tissues and optimize and monitor ongoing therapies21–23. In particular, there was great interest from radiotherapists to use the above 31P MRS
parameters as indicators of tumor tissue oxygenation. It has been found that one of the characteristic features of
31
P MRS spectra in tumors of both animals and patients is a low [NTP]/[Pi] ratio. It was realized that ATP levels
probably changed only under severe hypoxia while [Pi] might be more responsive to changes in tumor oxygenation throughout the physiological range. Note that it was concluded that dead cells contribute nothing to 31P
NMR spectra of Pi, which is apparently not present in necrotic regions24. However, in these works there were no
special efforts to discriminate NMR signals measured from phosphates localized in intracellular, extracellular and
vascular fluids which makes the analysis of the Pi spectra less conclusive. In general, the relationships of [ATP]/
[Pi] ratio to tumor tissue oxygenation was found to be obscure and less clear than in normal tissues, therefore,
the initial enthusiasm for 31P NMR use as a tool to monitor tumor tissue oxygenation and related treatment
outcome has been significantly suppressed. In subsequent studies, 31P NMR of endogenous phosphate became a
widely-used technique to assess intracellular pH (pHi) in vivo and was the primary method to demonstrate that
malignant cells keep their cytosolic pH rather slightly alkaline or neutral but not acidic24. Intracellular pH measurements using a 31P NMR signal is based on the high contribution of the signal from intracellular phosphate
(e.g., by estimate in ref. 24 at least 65% of the Pi signal used for pH measurements in rat tumors comes from the
Scientific Reports | 7:41233 | DOI: 10.1038/srep41233
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intracellular fluid). If intracellular pH is significantly different from pHe then the Pi peak could be broadened
or even split allowing for discrimination of intracellular and extracellular Pi signals using high-filed magnetic
resonance spectroscopy20.
An advantage of our EPR approach of Pi detection compared to 31P NMR is precise assignment of the measured [Pi] values to the known probe localization in interstitial extracellular space. Another important advantage
of a multifunctional probe is that all parameters are measured using a single probe, therefore allowing for their
correlation analyses independent of probe distribution and time of the measurements. Note that some heterogeneity in probe distribution (e.g. poor probe delivery in hypoxic/anoxic areas) may affect the average values of
the parameters measured in the spectroscopic modality and, therefore, partially mask the potential differences
between the parameters or decrease significance in correlation analysis. Nevertheless, we found that interstitial [Pi] negatively correlates with oxygen partial pressure, pO2, in all tissues: normal mammary gland (Fig. 3b),
spontaneous breast tumors in MMTV-PyMT mice (Fig. 5b), and PC14 and PC14HM tumor xenografts (Fig. 8b).
Establishing anoxic conditions in interstitial space by intratissue injection of oxygen-consuming enzymatic system of glucose/glucose oxidase further increased Pi levels (Figs 3b and 5b, red symbols). These observations are
in agreement with association of high Pi content (and low [NTP]/[Pi] ratio) with changes in bioenergetics status
upon lower oxygen supply12,21.
Interestingly, a positive correlation was observed between tissue pO2 and pHe in the normal mammary glands
(Fig. 3a) apparently reflecting higher contribution of glycolysis in tissue energy metabolism at lower pO2 accompanied by interstitial lactic acidosis. However, in contrast to normal mammary glands, no significant correlation
was found between pO2 and pHe in both spontaneous tumors (Fig. 5a) and tumor xenografts (Fig. 8a). In our
opinion, this is a direct in vivo experimental demonstration of the Warburg effect - tumor reliance on glycolysis
independent of oxygen concentration.
It is noteworthy that in all tumor tissues and normal mammary glands, we did not observe a correlation
between pHe and [Pi]. Apparently, this suggests that while both interstitial proton and phosphate concentrations
are affected by metabolic alterations, the specific pathways of their accumulation in tissue microenvironment can
be different.
Tumor acidosis is often considered to be a consequence of significant tumor metabolic reliance on glycolysis,
in part resulting in higher lactic acid production in tumors. Nevertheless, simple quantitative analysis shows
that a substantial quantity of acid equivalents production in tumor tissue comes from carbonic acid produced
via oxidative metabolism13. An alternative explanation for the acidity of TME is an insufficient rate of proton
transport from the site of generation, cancer cells, to capillaries due to a low density of tumor blood vessels.
While a carrier (buffer)-mediated H+ diffusion has been proposed to play a major role in proton transport in the
TME13,25, the contribution of interstitial phosphate buffer in proton transfer might be significantly larger, possibly
up to the order of magnitude compared to current estimates, for the following reasons. First, according to our
measurements, Pi concentrations in TME can be up to several fold higher compared to normal tissues. Second,
TME acidosis increases the concentration of the protonated H2PO4− form of phosphate, a proton carrier, by an
additional factor of 2–3 (for ΔpH ≈ 0.3–04).
The absence of correlation between pHe and [Pi] may be not surprising. While Pi can be considered as a major
proton carrier facilitating proton transfer from malignant cells towards capillaries, bicarbonate buffer has a much
higher concentration (10–30 mM26) compared to phosphate in interstitial fluids and, therefore, should play a primary role in pH buffering. On the other hand, concentration of carbonic acid, the protonated form of bicarbonate
and proton carrier, is negligible (pKa (H2CO3) = 3.6) even at acidic tumor pHe, therefore bicarbonate does not
contribute to proton transfer in TME. There is also an intriguing possibility discussed in the literature that acidic
pHe is under homeostatic control7,13.
Finally, elevated Pi levels in TME may reflect a high phosphorus content requirement for the malignant cells
derived from the “growth rate hypothesis” (GRH) application to cancer14,27,28. Inorganic phosphate is a vital component of nucleotides, membrane phospholipids, and phosphorylated intermediates in cellular signalling. The
GRH states that the carbon:nitrogen:phosphorus stoichiometry of living things, termed “biological stoichiometry29”, is associated with growth rate because of the elevated demands for phosphorus (P)-rich ribosomal RNA
for fast growing organisms (relatively low C:P and N:P cell content). The GRH hypothesis being applied to cancer
predicts that tumors are richer in phosphorus than the surrounding tissue due to the requirement of a high
amount of ribosomes and other P-rich RNA components that are necessary to manufacture proteins in rapidly
proliferating cancer cells. This was also suggested experimentally by significantly higher intracellular concentration of phosphorus in some types of tumors compared to somatic tissues14. The selective uptake of phosphorus
32
P by tumors upon intravenous injection of radioactive phosphate has been known since the 1940 report by
Marshak et al.30 supported by further observations31–33. Recently, Papaloucas et al.34 reported significantly higher
P content in the serum of a group of cancer patients measured before the commencement of any treatment (12
head and neck, 13 cervical and 25 non-small cell lung cancer cases) compared to a group of 50 healthy individuals. Unfortunately, there is a current uncertainty in whether the increased P content in the serum observed in
these cancer patients34 and elevated interstitial Pi content observed in various mouse model tumors in our work
is causal.
The observed negative correlation of interstitial [Pi] and pO2 in TME (Figs 5b and 8b) show that tumor metabolism might be at least partially responsible for elevated [Pi] values. Increases in [Pi] can be a direct consequence
of ATP hydrolysis upon low oxygen supply, and it may contribute to regulation of oxidative phosphorylation and
glycolysis in cells12 and phosphate-mediated proton diffusion from cells to capillaries13. Nevertheless, similar negative correlations between [Pi] and pO2 in normal tissue (Fig. 3b) assumes that the other factors may also play role
in establishing high interstitial Pi concentrations in TME. In this respect, note the absence of correlation of [Pi]
as well as pHe and pO2 with the tumor volume in TME of breast cancer in PyMT transgenic mice (Fig. 4) which
may reflect the establishment of TME favorable for tumor growth at the early phase of progression of spontaneous
Scientific Reports | 7:41233 | DOI: 10.1038/srep41233
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tumors. Numerical computations in accordance to GRH suggest that indeed increased inflow of extracellular
phosphorus promotes a shift towards a more rapidly proliferating cell type28. In contrast to the spontaneous
tumors, we observed a positive correlation between [Pi] and tumor volume for tumor xenografts which might be
related to the process of modifying normal tissue microenvironment during tumor progression after injection of
malignant cells. Recently, Carvalho and Caramujo proposed that metastases migration may be P-driven: tumor
metastasis would occur as an adaptation of tumor cells to fulfil their phosphorus requirements for rapid growth35.
Future studies are warranted to evaluate whether higher interstitial [Pi] in tumors compared to normal tissue,
and the amplification of interstitial Pi in highly-metastatic tumors compared to non-metastatic that we documented here have physiological significance and may provide additional avenues for therapy. Existing clinical
data suggest that the requirement of rapidly growing tumors for high P can have body-wide physiological consequences. Thus, oncological hypophosphatemia has been proposed to reflect transfer of serum Pi into proliferating
malignant cells36. The authors34 consider that increased amount of phosphorus in the blood, when excluding
other causes justifying such an increase, may indicate the existence of unidentified cancerous lesions, therefore
providing a quick and inexpensive method for detection of an emergence of cancer in the body. In our opinion,
measurement of interstitial [Pi] might be more sensitive and specific to cancer compared to blood measurements allowing for localized [Pi] measurements in tumor tissue. Interstitial Pi has been recently recognized as
an emerging signaling molecule playing a role in promoting cell transformation and tumorigenesis via specific
molecular mechanisms, including its mitogenic role that stimulates proliferation and matrix regulation, increases
in ATP production through oxidative phosphorylation, and promotion of angiogenesis37–42. The observation of
Pi-dependent mammographic microcalcifications for nonpalpable, early stage breast cancer43 also allows us to
suppose that interstitial Pi might be used as a prognostic factor in tumorigenesis. Identification of interstitial Pi
as a prognostic factor is of particular importance due to the current lack of predictive microscopic molecular biomarkers for evaluation of the relative risk of malignant transformation of pre-cancer lesions. Better understanding of the role of interstitial Pi in tumor progression may also help in the design of TME-targeted therapies aimed
at reversing a favorable environment that tumors create for themselves, such as neutralizing tumor acidosis44 and
controlling phosphorus and carbon availability.

Methods

Chemicals. Monophosphonated pTAM probe was synthesized as described in ref. 10. Glucose, glucose oxidase and salts were purchased from Sigma-Aldrich.
L-Band electron paramagnetic resonance studies. EPR measurements were performed using L-band
EPR spectrometer (Magnettech, Germany). The typical instrument settings were as follows: attenuation 24 dB;
modulation amplitude, 37.5 mG; modulation frequency, 100 kHz; sweep width, 0.9 G; sweep time, 20–60 s. The
high-field component of pTAM EPR spectra (see Fig. 1c) was acquired during a 5–10 minute time frame.
pH, oxygen and inorganic phosphate calibration of pTAM probe.

Calibration procedure was performed similar to those published in refs 9,10 at physiological temperature (37 °C), solution ionic strength (NaCl,
150 mM), and pTAM probe concentration, 0.2 mM.

pH calibration. pTAM solutions were titrated by addition of a small volume of NaOH or HCl with the final
dilution of sample less than 1%. pH was controlled by electrode calibrated at 37 °C using pH values for reference
solution recommended by National Bureau of Standards (U.S.). Temperature of reference and titrated solutions
during pH measurements was controlled using a jacketed reaction beaker attached to Lauda Circulator E100.
Anoxic conditions were maintained using 10 mM addition of glucose and 100 U/mL glucose oxidase (Sigma,
USA) to probe solutions.
[Pi] calibration. Solution of pTAM radical with pH value near pKa was titrated with various concentration of
phosphate. Temperature and anoxic conditions were maintained as described above.
pO2 calibration. Gas composition was controlled by bubbling solution with gas mixture delivered from gas controller (Noxygen, Germany). Solution temperature was controlled using water bath attached to the thermostat.

General description of analysis of the EPR spectra and calculation of probe spectral parameters.

Comprehensive analysis of pTAM probe EPR spectra was described in ref. 9 which takes into account the
contribution of exchange processes with oxygen, protons (pH) and phosphate into the lineshape (see Fig. 1c).
This allows for more accurate extraction of these parameters compared with the previously used procedure10.
Simulated high-field components of the pTAM probe EPR spectra were least-square fitted to experimental spectra with known pH, pO2 and [Pi] values and spectral parameters were extracted and used in further calculation of
unknown pH, pO2, and [Pi] values from in vivo experimental EPR spectra.

Simulation of high-field EPR spectra of pTAM probe. EPR spectrum of pTAM probe is characterized
by a doublet for pure pTAM3− (pH ≪ pKa, see Fig. 1b for the structure) or pTAM4− ionization states (pH ≫  pKa)
or by quartet at pH~pKa when both states are present (see Fig. 1c). In in vivo studies the acquisition of full EPR
spectra of pTAM probe is unpractical because of additional time used to acquire the gap between low-field and
high-field components of EPR spectrum and low-resolution of full spectrum compare to one-component spectrum. Insert in Fig. 1c shows the high-filed component of the EPR spectrum used in our work for further analysis.
Below we describe the EPR signal simulation procedure and calibration parameters for this specific component.
Spectra were simulated using theory of exchange between several sites in non-coupled or loosely coupled systems
adapted from ref. 45 as previously described for the pTAM spectra analysis9. Namely, EPR high-field component
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can be described as convolution of exchange function between high-filed component of acidic and basic ionization states of pTAM probe V(B) with Gaussian function of the unresolved super hyperfine structure of pTAM
probe:
F ( B) = C + D ⋅

∫

V (x ) ⋅ e

−2 ⋅ (x− B)2
G2

⋅

2 ⋅ ( x − B)
dx
π ⋅ G3

4⋅

(1)

where C and D are numerical coefficients; G is linewidth (in Gauss) of Gaussian distribution.
The exchange function V(B) can be described as follows:
V ( B) =

()

p 
2π ⋅ V ( ν )
2π
=
⋅ Re 1 K −1  a 
 pb 
1
γe
γe

(2)

1



− RO2
0



 T a

−r ab r ba
 − i  ν a 0  − ν ⋅ 1 0 
−
K= r



  0 ν b 
1
0 1 
ab − r ba

− RO2 
0


Tb


(

)

( )

(3)

where γe = 2.8 MHz/G - electron gyromagnetic ratio; pa and pb = (1 −  pa) – fraction of pTAM and pTAM4−
forms of pTAM probe, correspondingly; νa and νb are the frequency positions of high-field components of acidic
(pTAM 3− ) and basic (pTAM 4− ) forms of pTAM EPR spectrum, namely, ν a =  ν 0 −  0.5 ⋅ ν a − ν b and
νb =  ν0 +  0.5 ⋅ ν a − ν b , where ν a − ν b =  aP(pTAM3−) −  aP(pTAM4−), aP(pTAM3−) and aP(pTAM4−) are phosphorus hyperfine splitting constant for corresponding ionization state of pTAM probe (in Hz) and ν0 is frequency
offset; Ta and Tb are transverse relaxation times of pTAM3− and pTAM4− forms, correspondingly; RO2 is a the rate
of oxygen-induced relaxation for pTAM. Frequency exchange matrix is represented by symbols rab which are the
rate of frequency exchange between spectral line a (acidic form of pTAM, pTAM3−) and b (basic form of pTAM,
pTAM4−).
Frequency exchange between these two lines is determined by concentration of inorganic phosphate and can
be described by following equation
3−

pTAM3 − + HPO42 −  pTAM 4 − + H 2PO4−

The rate of proton loss by pTAM

3−

(4)

due to the proton transfer with reaction rate constant kf equals to

R Ha + = k f ⋅ [HPO42 −] = k f ⋅ B0 ⋅

+

KaB

H +

KaB

=

k f ⋅ B0
1+

pa

1 − pa

⋅

K aR
K aB

(5)

where Bo is a total concentration of phosphate buffer, KaB and KaR are ionization constants for inorganic phosphate

and phosphono group of pTAM, correspondingly. Therefore the rate constant kf can be found by linear approximation of dependence of R Ha + on buffer concentration, B0, measured at known pH value (values of pa, KaB, KaR can
be calculated if pH value is known). The value of reverse rate constant kr of reverse reaction of pTAM4− protonation can be directly calculated using following equation:
kr = k f ⋅

[p1 TAM3 −]

[p1 TAM 4 −]

⋅

[HPO42 −]
KaB
=
⋅
k
f
[H 2PO4−]
KaR

(6)

that provides simple relationship, kr=1.55·kf, for aqueous solutions with ionic strength 0.15 (150 mM NaCl).

Fitting of simulated spectra to experimental spectra.

In general case the spectrum shape F(B) is
determined by all the discussed parameters: C, D, pa, ν0, ν a − ν b , Ta, Tb, G, RO2, and R Ha +. In order to decrease a
number of variables, the intrinsic spectral parameters ν a − ν b , T a, T b, and G were first determined by
least-squares fitting of the function F(B) to experimental EPR spectra in anoxic solutions and low buffer
(Na-phosphate) concentration, i.e. RO2 and R Ha + ≪  1/Ta, 1/Tb. The fitting of EPR spectra of anoxic 150 mM NaCl
solution of 200 μM pTAM by eq. (1) yields the values aP(pTAM3−) = 3.63 G, 1/Ta = 23.6 mG for the spectrum
acquired at pH 5.5; and aP(pTAM4−) = 3.37 G, 1/Tb = 9 mG and G = 45 mG for the spectrum acquired at pH 9.0.
Using obtained intrinsic parameters for both acidic and basic forms of pTAM (linewidth, 1/Ta and 1/Tb;
hyperfine splitting, ap), spectra of pTAM probe at different pH values were fitted to yield pa values and to plot the
dependence of pa value on pH. Fitting of this dependence with standard titration curve yields the value of the
dissociation constant, pKaR =  6.9.
To assess the sensitivity of pTAM probe to oxygen partial pressure, EPR spectra were fitted with equation (1)
using the intrinsic spectral EPR parameters listed above. The determined relaxation rates RO2 show linear dependence on pO2 values both for acidic (pH 5.5, pTAM3−) and basic (pH 9, pTAM4−) ionization states with the similar
values of spectral oxygen sensitivity, 0.49 mG/mmHg.
Fitting the EPR spectra of pTAM at different concentrations of Na-phosphate buffer and fixed pH value close
to pKaR (pH 6.9) was performed and the linear approximation of R Ha + dependence on phosphate concentration
was obtained yielding the value of kf = 8 mG/mM.
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Simulation and least-square fitting of EPR spectra were performed using Matlab software.

Animals. All animal work was performed in accordance with the OSU IACUC approved protocol.
PyMT spontaneous tumor model. Twelve week-old female Friend virus B-type susceptibility/NIH (FVB/N) polyoma middle-T antigen (PyMT+/−) mice (7 animals) with spontaneously formed mammary tumors were used
for in vivo EPR studies. For comparison of tissue microenvironments of normal mammary glands and tumors,
age-matched littermate females (3 animals) absent of the PyMT oncogene (PyMT−/−) were used15. Mice were
subject to L-band EPR spectroscopy one time per week for total of 4 weeks. Two to three mammary tumors (from
PyMT(+) mice) or non-tumor bearing mammary glands (from PyMT(−) mice) were measured at one time.
PC14/PC14HM tumor xenograft model. We compared s.c. xenografts established in NSG (NOD scid gamma)
immune deficient mice (NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ, Jackson Laboratory, Stock No: 005557) by injecting
human lung adenocarcinoma cells that differ in their metastatic properties: whereas parental PC14 cells rarely
forms metastases, PC14HM cells derived from these rare lung metastases is highly metastatic to various organs
including lung16. To evaluate the degree of tumor vascularization, tumor tissue sections were stained with
peroxidase-labeled antibody to the endothelial cell marker CD34 (Santa Cruz Biotechnology, Santa Cruz, CA)
and the number of tumor blood vessels was counted. Images were processed using ImageJ (National Institutes of
Health, Bethesda, MD) software. Ten fields on two nonadjacent sections were counted.
PC14 and PC14HM cells were generously provided by Dr. Shimizu K., Department of Thoracic and Visceral
Organ Surgery, Gunma University Graduate School of Medicine and maintained as described earlier16. NSG mice
were obtained from Jackson Laboratory. Eight animals were s.c. injected with 5 ×  106 cells (PC14 or PC14HM
cells) into the flanks of NSG mice to initiate tumors. Lung tumors were established by retro-orbital injection of
106 cells. Mice were sacrificed on day 18. Lung tumor nodules were visualized by H&E staining of whole lung
sections; nodules were counted in three non-adjacent sections using Eclipse E600 microscope (Nikon).
Tumor volume was determined by external measurements using equation, V =  [L ×  W2] × 0.5, where V is
volume, L is length, and W is width46.
In Vivo L-Band EPR Studies. Mice were narcotized by inhalation of air-isoflurane mixture using Ohmeda
Fluotec 3 anesthetic machine and then placed into the gap of L-band (1.2 GHz) EPR spectrometer (Magnettech,
Germany). The surface coil resonator was placed onto normal mammary gland or mammary tumor/tumor xenograft and spectrometer was tuned. Solutions of the pTAM probe (0.5−2 mM, 10−30 μL) in saline, pH 7.2 was
injected intratissually. Immediately after injection the EPR spectra were acquired for 5−10 min.
Local anoxic conditions in place of intratissual probe injection were initiated and maintained by addition of
glucose (10 mM) and glucose oxidase (100 U/ml) into injecting solution. This combination of glucose/glucose
oxidase is able to consume oxygen to level less than 1 mmHg in several seconds and maintain this low value
locally at least for 10 min.

Statistical analysis. Data processing and statistical analysis was performed using OriginPro software package. Correlation analysis of experimental data was performed using Pearson’s r Correlation test (for normally
distributed datasets) and Spearman’s Rank Order Correlation (for datasets with rejected normality of data distribution). All datasets pass normality test (data are normally distributed) except total dataset of pO2 values for
PyMT mice (see Fig. 3 black +  red symbols).
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